Martingale Asset Management L P Sells 16,946 Shares of Encompass Health Corporation $EHC

Key Points

• Martingale Asset Management L P reduced its stake in Encompass Health Corporation by 10.8%, ending the quarter with 140,639 shares valued at approximately $14.24 million.
• Multiple institutional investors have also adjusted their holdings in Encompass Health, with over 97.25% of the stock owned by these investors.
• Encompass Health recently raised its quarterly dividend to $0.19 from $0.17, representing an annualized yield of 0.6%.

Martingale Asset Management L P reduced its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 10.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 140,639 shares of the company's stock after selling 16,946 shares during the quarter. Martingale Asset Management L P owned about 0.14% of Encompass Health worth $14,244,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its stake in Encompass Health by 25.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock valued at $210,756,000 after buying an additional 424,691 shares during the period. Capital Fund Management S.A. acquired a new position in shares of Encompass Health in the 1st quarter valued at about $1,124,000. Credit Agricole S A lifted its position in shares of Encompass Health by 71.1% in the first quarter. Credit Agricole S A now owns 23,073 shares of the company's stock worth $2,337,000 after purchasing an additional 9,584 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. lifted its position in Encompass Health by 80.8% in the 1st quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 9,836 shares of the company's stock worth $992,000 after buying an additional 4,396 shares in the last quarter. Finally, Hsbc Holdings PLC boosted its stake in shares of Encompass Health by 85.1% during the 1st quarter. Hsbc Holdings PLC now owns 77,235 shares of the company's stock valued at $7,778,000 after buying an additional 35,513 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. KeyCorp raised their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Royal Bank Of Canada boosted their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. UBS Group raised their target price on Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Finally, Barclays upped their target price on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus price target of $134.00.

Encompass Health Trading Down 0.5%

NYSE EHC traded down $0.67 on Friday, reaching $122.76. The company had a trading volume of 798,000 shares, compared to its average volume of 895,065. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $124.67. The stock's 50 day moving average is $116.38 and its 200-day moving average is $110.32. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a market cap of $12.36 billion, a price-to-earnings ratio of 24.02, a PEG ratio of 2.15 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.20. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm's revenue was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is currently 13.31%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.